VF
PTPI

Virtu Financial’s Petros Pharmaceuticals PTPI Stock Holding History

Virtu Financial’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,810
Closed -$32K – 1790
2024
Q2 		$32K Buy
+2,810
New +$45.1K ﹤0.01% 972
2024
Q1 		– Sell
-993
Closed -$35K – 1959
2023
Q4 		$35K Buy
+993
New +$35.5K ﹤0.01% 1232
2022
Q3 		– Sell
-214
Closed -$44K – 2137
2022
Q2 		$44K Buy
+214
New +$53.6K ﹤0.01% 1155
2022
Q1 		– Sell
-212
Closed -$177K – 1928
2021
Q4 		$177K Buy
+212
New +$124K 0.02% 879
2021
Q3 		– Sell
-57
Closed -$45K – 1866
2021
Q2 		$45K Buy
+57
New +$45.6K ﹤0.01% 1350

Other funds holding PTPI

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's PTPI Position: Q3 2024 in Review

Virtu Financial sold out of Petros Pharmaceuticals (PTPI) in Q3 2024, closing a stake of 2,810 shares — an estimated $32K sold.

Virtu Financial first reported a position in PTPI in Q2 2021 and held it in 5 quarters. The position peaked at $177K in Q4 2021. 11 funds tracked by Wall St. Rank hold PTPI as of Q3 2024.

  • Virtu Financial reported no remaining Petros Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 2,810 Petros Pharmaceuticals shares in Q3 2024, an estimated $32K.
  • Virtu Financial first reported a position in Petros Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Virtu Financial's Petros Pharmaceuticals position peaked at $177K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.